Journal article icon

Journal article

Timeliness of reporting of SARS-CoV-2 seroprevalence results and their utility for infectious disease surveillance

Abstract:

Seroprevalence studies have been used throughout the COVID-19 pandemic to monitor infection and immunity. These studies are often reported in peer-reviewed journals, but the academic writing and publishing process can delay reporting and thereby public health action. Seroprevalence estimates have been reported faster in preprints and media, but with concerns about data quality. We aimed to (i) describe the timeliness of SARS-CoV-2 serosurveillance reporting by publication venue and study char...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1016/j.epidem.2022.100645

Authors


Publisher:
Elsevier
Journal:
Epidemics More from this journal
Volume:
41
Article number:
100645
Place of publication:
Netherlands
Publication date:
2022-10-20
Acceptance date:
2022-10-19
DOI:
EISSN:
1878-0067
ISSN:
1755-4365
Pmid:
36308993
Language:
English
Keywords:
Pubs id:
1299972
Local pid:
pubs:1299972
Deposit date:
2023-02-03

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP